COVID-19 modelling expert explains why it’s going to be trickier than many people think to vaccinate ourselves out of Delta Even as vaccination rates rise across Australia, it is unlikely that risk-averse medical practices will be allowing pharmaceutical reps to engage in face-to-face visits any time soon. So how can new digital GTM channels help to close this gap? The only certainty
A leading pharmaceutical company asked ADG to design a campaign encouraging GPs to follow updated treatment guidelines and build their knowledge and confidence to initiate prescriptions of its product.
Research study reveals GP registrars carry heavy burden of responsibility without life experience to rely on, and tools pharma can use to help GP registrars are under such stress that they are seeking out peers and crowd support to help them feel more confident in their jobs, an AusDoc survey has revealed. The Project Pathway
Meet John Betsis from the Gold Coast, diagnosed with mitochondrial disease in his late teens.
Research study shows how to better support and educate this crucial market GPs are expected to stay up-to-date with the constant changes in medicine yet, with the myriad information available, they must still navigate and interrogate multiple sources to find what they need. This information overload takes time away from the main source of GPs’ job
Survey uncovers what medical students need and how best to connect with them Helping medical students to succeed in their studies is a key factor in getting their attention, a recent ADG survey* has found. The survey, conducted in February 2021, asked students in their final two years of study about the tensions they face and what they need
Hologic tasked ADG to promote its leading gynaecological product to help close knowledge gaps among GPs and address both over and undertreatment for heavy menstrual bleeding.
A leading brand in the Women’s Health market tasked ADG to deliver growth and maintain profitability of the brand through a digital only plan. GPs who engaged in 4 or more Access.PLUS articles had a 14% higher prescription rate vs the market and non-engaged GPs.
The Royal College of Pathologists of Australasia (RCPA), with funding from the Australian Government Department of Health, partnered with ADG to help promote the quality use of pathology to GPs and other health professionals.
A leading brand in the type 1 and type 2 diabetes market asked ADG to support the launch of a new product. The campaign resulted a 3-fold increase in scripts among eDetailed GPs.
A chronic insomnia brand tasked ADG to help them challenge the way GPs think about the diagnosis and treatment of insomnia and to drive the launch of new science (a sleep/wake system) and treatment options. Within the first two weeks of launch 1,740 GPs had viewed the brand eDetails.
With the sudden and dramatic impact of COVID-19, a survey of GPs and their contact with pharmaceutical field staff during the pandemic reveals a massive drop in face-to-face engagement. The joint Australian Doctor Group and Medicines Australia poll was sent out in mid-May and attracted almost 400 responders. It shows prior to the pandemic half